Form 4: Alphatec Holdings CEO Patrick Miles Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alphatec Holdings CEO Patrick Miles sold 43,459 shares of common stock on February 5, 2025, to satisfy tax withholding obligations related to vesting restricted stock units.
Summary
- On February 5, 2025, Patrick Miles, CEO of Alphatec Holdings, Inc. (ATEC), sold 43,459 shares of common stock.
- The sale was executed at a weighted average price of $11.95 per share, with individual transactions ranging from $11.81 to $12.14.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 13, 2024.
- The purpose of the sale was to cover tax withholding obligations arising from the vesting of restricted stock units.
- Following the transaction, Miles directly owns 6,065,772 shares of Alphatec Holdings, Inc.
- Miles also indirectly owns 10,900 shares through an IRA and 250,000 shares through MOM, LLC.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, executed under a pre-existing plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Future Outlook
There is no future outlook information provided in this document.
Industry Context
This is a routine Form 4 filing related to insider trading activity. It is common for executives to sell shares to cover tax obligations, especially after vesting of restricted stock units. The existence of a pre-arranged 10b5-1 trading plan suggests the sale was planned and not based on any specific non-public information.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The use of a 10b5-1 trading plan is a common method for executives to sell shares without raising concerns about insider trading, aligning with industry best practices.
- Comparing the volume of shares sold and the value of the transaction to similar transactions by executives at comparable medical device companies (e.g., Medtronic, Stryker, Johnson & Johnson's DePuy Synthes) would provide further context, but that data is not available in this document.
Stakeholder Impact
- The sale of shares by the CEO could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-06-13 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-02-05 | Date of stock sale transaction |
| 2025-02-07 | Date of Form 4 filing |
Keywords
Alphatec Holdings, ATEC, Patrick Miles, stock sale, Form 4, Rule 10b5-1, tax obligations, restricted stock units, CEO, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.